Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Neuron|May 8, 2007
Behavioral phenotypes of Disc1 missense mutations in miceSteven J Clapcote, Tatiana V Lipina, J Kirsty Millar, et al.
Health Technology Assessment (Winchester, England)|October 27, 2020
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysisNigel Armstrong, Nasuh Büyükkaramikli, Hannah Penton, et al.
Evolutionary Applications|June 22, 2018
Genotyping-by-sequencing of genome-wide microsatellite loci reveals fine-scale harvest composition in a coastal Atlantic salmon fisheryIan R Bradbury, Brendan F Wringe, Beth Watson, et al.
The EMBO Journal|July 4, 2003
Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor traffickingMartina Metzler, Bo Li, Lu Gan, et al.
Evolutionary Applications|October 3, 2022
Genomic evidence of recent European introgression into North American farmed and wild Atlantic salmonIan R Bradbury, Sarah Jean Lehnert, Tony Kess, et al.
Pharmacoeconomics|February 9, 2023
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMohamed N M T Al Khayat, Nigel Armstrong, Jeremy Howick, et al.
Human Molecular Genetics|May 6, 2010
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regionsTao Yu, Zhongyou Li, Zhengping Jia, et al.
Health Technology Assessment (Winchester, England)|July 16, 2015
Clinical effectiveness and cost-effectiveness of parenting interventions for children with severe attachment problems: a systematic review and meta-analysisBarry Wright, Melissa Barry, Ellen Hughes, et al.
Ecology and Evolution|April 8, 2024
Variable parallelism in the genomic basis of age at maturity across spatial scales in Atlantic SalmonTony Kess, Sarah J Lehnert, Paul Bentzen, et al.
Pharmacoeconomics|November 4, 2020
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalWillem J A Witlox, Sabine E Grimm, Rob Riemsma, et al.
Pageof 14